{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:12:54Z","timestamp":1782756774038,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,9]]},"DOI":"10.7759\/cureus.14913","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T07:30:12Z","timestamp":1620545412000},"source":"Crossref","is-referenced-by-count":9,"title":["Review on Pneumococcal Infection in Children"],"prefix":"10.7759","author":[{"given":"Vijayakumary","family":"Thadchanamoorthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavinda","family":"Dayasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pneumococcal conjugate vaccine for childhood immunization-WHO position paper","volume":"82","author":"WHO","year":"2007","unstructured":"WHO. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec. Geneva: World Health Organization. 2007, 82:93-104.","journal-title":"Wkly Epidemiol Rec. Geneva: World Health Organization"},{"key":"ref2","article-title":"Sherris Medical Microbiology","author":"Ryan KJ; Ray CG","year":"2004","unstructured":"Ryan KJ; Ray CG, eds. Sherris Medical Microbiology. McGraw Hill, New York; 2004."},{"key":"ref3","article-title":"Preventing pneumococcal diseases among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Advisory Committee on Immunization Practices","year":"2000","unstructured":"Advisory Committee on Immunization Practices. Preventing pneumococcal diseases among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000, 49:1-35.","journal-title":"MMWR Recomm Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff WP","year":"2005","unstructured":"Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005, 5:83-93. 10.1016\/S1473-3099(05)01280-6","journal-title":"Lancet Infect Dis"},{"key":"ref5","article-title":"Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep. 2010, 59:253-7.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1997.3.141","article-title":"Prevalence of serotypes and antimicrobial resistance of streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America","volume":"3","author":"Brandileone MC","year":"1997","unstructured":"Brandileone MC, Vieira VS, Casagrande ST, et al.. Prevalence of serotypes and antimicrobial resistance of streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America. Microb Drug Resist. 1997, 3:141-6. 10.1089\/mdr.1997.3.141","journal-title":"Microb Drug Resist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508243330803","article-title":"The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta","volume":"333","author":"Hofmann J","year":"1995","unstructured":"Hofmann J, Cetron MS, Farley MM, et al.. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995, 333:481-6. 10.1056\/NEJM199508243330803","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199804000-00005","article-title":"Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country","volume":"17","author":"Levine MM","year":"1998","unstructured":"Levine MM, Lagos R, Levine OS, et al.. Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country. Pediatr Infect Dis J. 1998, 17:287-93. 10.1097\/00006454-199804000-00005","journal-title":"Pediatr Infect Dis J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy","volume":"270","author":"Butler JC","year":"1993","unstructured":"Butler JC,  Breiman RF, Campbell JF, et al.. Pneumococcal polysaccharide vaccine efficacy. JAMA. 1993, 270:1826-31. 10.1001\/jama.1993.03510150060030","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/11205110-000000000-00000","article-title":"Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13\u00ae]","volume":"70","author":"Duggan ST","year":"2010","unstructured":"Duggan ST. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13\u00ae]. Drugs. 2010, 70:1973-86. 10.2165\/11205110-000000000-00000","journal-title":"Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1695-4033(02)77957-5","article-title":"Bacteremic pneumococcal pneumonia","volume":"57","author":"Pineda SV","year":"2002","unstructured":"Pineda SV, Perez BA, Domingo PM.. Bacteremic pneumococcal pneumonia. An Esp Pediatr. 2002, 57:408-13. 10.1016\/S1695-4033(02)77957-5","journal-title":"An Esp Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2000.04429.x","article-title":"Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia","volume":"15","author":"Brandenburg JA","year":"2000","unstructured":"Brandenburg JA, Marrie TJ, Coley CM, Singer DE, Obrosky DS, Kapoor WN, Fine MJ. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med. 2000, 15:638-46. 10.1046\/j.1525-1497.2000.04429.x","journal-title":"J Gen Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.752","article-title":"Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial","volume":"174","author":"Zangwill KM","year":"1996","unstructured":"Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis. 1996, 174:752-9. 10.1093\/infdis\/174.4.752","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney CG","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, et al.. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003, 348:1737-46. 10.1056\/NEJMoa022823","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan SL","year":"2004","unstructured":"Kaplan SL, Mason EO Jr, Wald ER, et al.. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004, 113:443-9. 10.1542\/peds.113.3.443","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.121","article-title":"Declining invasive pneumococcal disease mortality in the United States, 1990-2005","volume":"28","author":"Pulido M","year":"2010","unstructured":"Pulido M, Sorvillo F. Declining invasive pneumococcal disease mortality in the United States, 1990-2005. Vaccine. 2010, 28:889-92. 10.1016\/j.vaccine.2009.10.121","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.04.026","article-title":"Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations","volume":"26","author":"L\u00f8chen A","year":"2020","unstructured":"L\u00f8chen A, Anderson RM. Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clin Microbiol Infect. 2020, 26:60-7. 10.1016\/j.cmi.2019.04.026","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser JN","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018, 16:355-67. 10.1038\/s41579-018-0001-8","journal-title":"Nat Rev Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02611.x","article-title":"The role of pneumolysin in pneumococcal pneumonia and meningitis","volume":"138","author":"Hirst RA","year":"2004","unstructured":"Hirst RA, Kadioglu A, O'callaghan C, Andrew PW. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol. 2004, 138:195-201. 10.1111\/j.1365-2249.2004.02611.x","journal-title":"Clin Exp Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/iai.68.7.3990-3997.2000","article-title":"Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract","volume":"68","author":"Pericone CD","year":"2000","unstructured":"Pericone CD, Overweg K, Hermans PW, Weiser JN. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 2000, 68:3990-7. 10.1128\/iai.68.7.3990-3997.2000","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00317-06","article-title":"Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae","volume":"188","author":"Regev-Yochay G","year":"2006","unstructured":"Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol. 2006, 188:4996-5001. 10.1128\/JB.00317-06","journal-title":"J Bacteriol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511017103","article-title":"A pneumococcal pilus influences virulence and host inflammatory responses","volume":"103","author":"Barocchi MA","year":"2006","unstructured":"Barocchi MA, Ries J, Zogaj X, et al.. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A. 2006, 103:2857-62. 10.1073\/pnas.0511017103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-314","article-title":"The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study","volume":"11","author":"Siemieniuk RA","year":"2011","unstructured":"Siemieniuk RA, Gregson DB, Gill MJ. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infect Dis. 2011, 11:314. 10.1186\/1471-2334-11-314","journal-title":"BMC Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1086\/649208","article-title":"Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States","volume":"50","author":"Walter ND","year":"2010","unstructured":"Walter ND, Taylor TH, Shay DK, Thompson WW, Brammer L, Dowell SF, Moore MR. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis. 2010, 50:175-83. 10.1086\/649208","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.362","article-title":"American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis","volume":"106","year":"2000","unstructured":"American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement. recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000, 106:362-6. 10.1542\/peds.106.2.362","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson KA","year":"2001","unstructured":"Robinson KA, Baughman W, Rothrock G, et al.. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA. 2001, 285:1729-35. 10.1001\/jama.285.13.1729","journal-title":"JAMA"},{"key":"ref27","article-title":"Pneumococcal pneumonia: epidemiology and clinical features","volume":"14","author":"Marrie TJ","year":"1999","unstructured":"Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect. 1999, 14:227-36.","journal-title":"Semin Respir Infect"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00013-11","article-title":"Polymicrobial interactions: impact on pathogenesis and human disease","volume":"25","author":"Peters BM","year":"2012","unstructured":"Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev. 2012, 25:193-21. 10.1128\/CMR.00013-11","journal-title":"Clin Microbiol Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.07.005","article-title":"Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae","volume":"117","author":"Anon JB","year":"2004","unstructured":"Anon JB. Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae. Am J Med. 2004, 117:23S-8. 10.1016\/j.amjmed.2004.07.005","journal-title":"Am J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0623","article-title":"Bacterial bronchitis caused by Streptococcus pneumoniae and nontypable Haemophilus influenzae in children: the impact of vaccination","volume":"143","author":"Priftis KN","year":"2013","unstructured":"Priftis KN, Litt D, Manglani S, et al.. Bacterial bronchitis caused by Streptococcus pneumoniae and nontypable Haemophilus influenzae in children: the impact of vaccination. Chest. 2013, 143:152-7. 10.1378\/chest.12-0623","journal-title":"Chest"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371404","article-title":"Bacterial meningitis in the United States in 1995. Active Surveillance Team","volume":"337","author":"Schuchat A","year":"1997","unstructured":"Schuchat A, Robinson K, Wenger JD, et al.. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997, 337:970-6. 10.1056\/NEJM199710023371404","journal-title":"N Engl J Med"},{"key":"ref32","unstructured":"Bacterial meningitis CDC. (2014). Accessed. 5 March 2016:"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome","volume":"28","author":"R\u00fcckinger S","year":"2009","unstructured":"R\u00fcckinger S, von Kries R, Siedler A, van der Linden M. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J. 2009, 28:118-22. 10.1097\/INF.0b013e318187e215","journal-title":"Pediatr Infect Dis J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420050065040","article-title":"Invasive pneumococcal disease in an Alaska native population, 1980 through 1986","volume":"261","author":"Davidson M","year":"1989","unstructured":"Davidson M, Schraer CD, Parkinson AJ, et al.. Invasive pneumococcal disease in an Alaska native population, 1980 through 1986. JAMA . 1989, 261:715-8. 10.1001\/jama.1989.03420050065040","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e3181e15e36","article-title":"Occult pneumococcal bacteremia: a review","volume":"26","author":"Joffe MD","year":"2010","unstructured":"Joffe MD, Alpern ER. Occult pneumococcal bacteremia: a review. Pediatr Emerg Care. 2010, 26:448-54. 10.1097\/PEC.0b013e3181e15e36","journal-title":"Pediatr Emerg Care"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(98)70225-2","article-title":"Predictors of occult pneumococcal bacteremia in young febrile children","volume":"31","author":"Kuppermann N","year":"1998","unstructured":"Kuppermann N, Fleisher GR, Jaffe DM.  Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med. 1998, 31:679-87. 10.1016\/S0196-0644(98)70225-2","journal-title":"Ann Emerg Med"},{"key":"ref37","article-title":"Pneumococcal diseases in children:morbidity, mortality, and resistance","volume":"1","author":"Malley R","year":"1998","unstructured":"Malley R, Ambrosino D . Pneumococcal diseases in children:morbidity, mortality, and resistance. Univ Chicago Child Hosp Rep Curr Concepts Use Pediatr Vaccines. 1998, 1:1-8.","journal-title":"Univ Chicago Child Hosp Rep Curr Concepts Use Pediatr Vaccines"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1981.03320170054034","article-title":"Pneumococcal infections","volume":"246","author":"Mufson MA","year":"1981","unstructured":"Mufson MA . Pneumococcal infections. JAMA. 1981, 246:1942-8.","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7549.1077","article-title":"Pneumonia: update on diagnosis and management","volume":"332","author":"Hoare Z","year":"2006","unstructured":"Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ. 2006, 332:1077-9. 10.1136\/bmj.332.7549.1077","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger DM","year":"2010","unstructured":"Weinberger DM, Harboe ZB, Sanders EA, et al.. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010, 51:692-9. 10.1086\/655828","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1086\/528798","article-title":"Medical microbiology: laboratory diagnosis of invasive pneumococcal disease","volume":"46","author":"Werno AM","year":"2008","unstructured":"Werno AM, Murdoch DR. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis. 2008, 46:926-32. 10.1086\/528798","journal-title":"Clin Infect Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60350-5","article-title":"Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study","volume":"371","author":"Von Gottberg A","year":"2008","unstructured":"Von Gottberg A, Klugman KP, Cohen C, et al.. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. The Lancet. 2008, 371:1108-13. 10.1016\/S0140-6736(08)60350-5","journal-title":"The Lancet"},{"key":"ref43","article-title":"Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","unstructured":"Centers for Disease Control and Prevention. Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1997, 46:1-24.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-3955(05)70207-8","article-title":"Pneumococcal vaccine","volume":"47","author":"Rubin LG","year":"2000","unstructured":"Rubin LG. Pneumococcal vaccine. Pediatr Clin North Am. 2000, 47:269-85. 10.1016\/s0031-3955(05)70207-8","journal-title":"Pediatr Clin North Am"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro ED","year":"1991","unstructured":"Shapiro ED, Berg AT, Austrian R, et al.. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991, 325:1453-60. 10.1056\/NEJM199111213252101","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00514-0","article-title":"Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence","volume":"3","author":"Mangtani P","year":"2003","unstructured":"Mangtani P, Cutts F, Hall AJ. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis. 2003, 3:71-8. 10.1016\/S1473-3099(03)00514-0","journal-title":"Lancet Infect Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien KL","year":"2009","unstructured":"O'Brien KL, Wolfson LJ, Watt JP, et al.. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009, 374:893-902. 10.1016\/S0140-6736(09)61204-6","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.68","article-title":"Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine","volume":"8","author":"Dinleyici EC","year":"2009","unstructured":"Dinleyici EC, Yargic ZA. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Rev Vaccines. 2009, 8:977-86. 10.1586\/erv.09.68","journal-title":"Expert Rev Vaccines"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage","author":"Prymula R","year":"2011","unstructured":"Prymula R, Hanovcova I, Splino M, et al.. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. 2011. 10.1016\/j.vaccine.2010.12.086"},{"key":"ref50","unstructured":"Vaccination funding landscape. (2012). https.\/\/www.givewell.org\/international\/charities\/vaccination-organizations."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55060-review-on-pneumococcal-infection-in-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:40Z","timestamp":1707506800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55060-review-on-pneumococcal-infection-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,9]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.14913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,9]]}}}